Funder
National Institutes of Health
Takeda Pharmaceuticals U.S.A.
Foundation for Women and Girls with Blood Disorders
Reference31 articles.
1. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease;James;Blood Adv,2021
2. Von Willebrand factor and disease: a review for laboratory professionals;Harris;Crit Rev Clin Lab Sci,2022
3. Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources;Favaloro;Res Pract Thromb Haemost,2023
4. Shear-dependent platelet aggregation: mechanisms and therapeutic opportunities;Rana;Front Cardiovasc Med,2019
5. Crystal structure and substrate-induced activation of ADAMTS13;Petri;Nat Commun,2019